Vanda Pharmaceuticals Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Vanda Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 58.3M shares, a 1.29% increase year-over-year.
  • Vanda Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 57.4M shares, a 1.63% increase from 2022.
  • Vanda Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 56.5M shares, a 1.65% increase from 2021.
  • Vanda Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 55.5M shares, a 2.06% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 58.3M +743K +1.29% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 58.2M +767K +1.34% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 57.8M +750K +1.32% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 57.4M +919K +1.63% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-08
Q3 2023 57.5M +945K +1.67% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 57.5M +945K +1.67% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 57M +906K +1.62% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 56.5M +914K +1.65% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-08
Q3 2022 56.6M +906K +1.63% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 56.5M +926K +1.67% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 56.1M +959K +1.74% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 55.5M +1.12M +2.06% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-08
Q3 2021 55.7M +1M +1.83% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 55.6M +1.08M +1.99% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 55.1M +1.34M +2.49% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 54.4M +1.29M +2.43% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 54.7M +1.37M +2.57% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 54.5M +1.4M +2.64% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 53.8M +1.05M +2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 53.1M +2.28M +4.48% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 53.3M +908K +1.73% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 53.1M +929K +1.78% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 52.8M +6.42M +13.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 50.9M +6.12M +13.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-11
Q3 2018 52.4M +7.5M +16.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 52.2M +7.45M +16.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 46.3M +1.94M +4.37% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 44.7M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 44.9M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 44.7M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 44.4M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2013 30.4M +2.12M +7.52% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-12
Q3 2013 31.3M +3.11M +11% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-08
Q2 2013 28.4M +151K +0.53% Apr 1, 2013 Jun 30, 2013 10-Q 2013-07-31
Q1 2013 28.3M +119K +0.42% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-10
Q4 2012 28.2M +122K +0.43% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 28.2M +119K +0.43% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 28.2M +123K +0.44% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 28.2M +125K +0.45% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 28.1M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 28.1M +104K +0.37% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 28.1M +207K +0.74% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 28.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 28M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 27.9M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.